Yesterday, Fagron hosted a Capital Markets Day where it laid out its strategic priorities for 2030. We see the updated Compounding for Growth strategy as a natural extension of the successful current trajectory. Financial targets are set for HSD-LDD organic CER revenue growth, a 21.0% REBITDA margin by 2027 progressively increasing thereafter to 2030, =70% operating cash conversion, =50% FCF conversion and 3.5% maintenance capex. Management continues to expect solid organic growth across all reg...
Ekinops has reported Q1 2025 revenue of EUR28.5m, up 1% yoy, extending the run of quarterly prints within the EUR28–30m range, with no discernible inflection. Underlying dynamics remain uneven: North America declined 20% yoy, offset by a 21% rebound in EMEA; Access Solutions rose 11%, while Optical
Fagron publishes agenda for 2025 annual shareholders meeting Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 11 April 2025 – 8 AM CET Fagron publishes agenda for 2025 annual shareholders meeting The Board of Directors of Fagron NV invites shareholders to attend Fagron’s annual general meeting of shareholders on Monday 12 May 2025. AgendaThe agenda includes the discussion of the annual report, the approval of the annual financial statements and the dividend proposal of €0.35 for the financial year 2024, and the approval of the remuneration policy. The full agenda and ...
Fagron publiceert agenda jaarlijkse aandeelhouders-vergadering 2025 Gereglementeerde informatieNazareth (België)/Rotterdam (Nederland), 11 april 2025 – 8u CET Fagron publiceert agenda jaarlijkse aandeelhouders-vergadering 2025 De Raad van Bestuur van Fagron NV nodigt de aandeelhouders uit om de jaarlijkse algemene vergadering van aandeelhouders van Fagron bij te wonen op maandag 12 mei 2025. AgendaOp de agenda staan onder andere de bespreking van het jaarverslag, de goedkeuring van de jaarrekening en het dividendvoorstel van €0,35 over het boekjaar 2024 en de goedkeuring van het remun...
A director at Wienerberger AG bought 10,000 shares at 27.266EUR and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
1Q25 results outperformed our and CSS expectations on the back of sustained high growth in N-Am's activities and strong CER performance in LatAm. The company reiterates its FY25 guidance and provides realistic mid-term targets into 2030 at today's CMD. We reiterate € 24 TP/ Buy rating.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.